Risk Stratification for Advanced Colorectal Neoplasia According to Fecal Hemoglobin Concentration in a Colorectal Cancer Screening Program

被引:91
|
作者
Auge, Josep M. [1 ]
Pellise, Maria [2 ]
Escudero, Jose M. [1 ]
Hernandez, Cristina [3 ]
Andreu, Montserrat [4 ]
Grau, Jaume [5 ]
Buron, Andrea [3 ]
Lopez-Ceron, Maria [2 ]
Bessa, Xavier [4 ]
Serradesanferm, Anna [5 ]
Piraces, Merce [3 ]
Macia, Francesc [3 ]
Guayta, Rafael [6 ]
Filella, Xavier [1 ]
Molina, Rafael [1 ]
Jimenez, Wladimiro [1 ]
Castells, Antoni [2 ]
机构
[1] Hosp Clin Barcelona, Biochem & Mol Genet Dept, E-08036 Barcelona, Spain
[2] Univ Barcelona, Dept Gastroenterol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer,Ctr Invest, Barcelona, Spain
[3] Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain
[4] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain
[5] Univ Barcelona, Hosp Clin, Prevent Med & Hosp Epidemiol Dept, Barcelona, Spain
[6] Council Coll Pharmacists Catalonia, Barcelona, Spain
关键词
Colorectal Cancer Screening; Fecal Immunochemical Tests; Colonoscopy; Risk Stratification; OCCULT BLOOD-TEST; IMMUNOCHEMICAL TEST; AVERAGE RISK; TESTS; COLONOSCOPY; POPULATION; PERFORMANCE; PREDICTION; SIGMOIDOSCOPY; SURVEILLANCE;
D O I
10.1053/j.gastro.2014.06.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The latest generation of fecal immunochemical tests (FIT) allows for quantitation of hemoglobin in feces, allowing for selection of optimal cut-off concentrations. We investigated whether individuals with positive results from quantitative FITs, in combination with other factors, could be identified as being at greatest risk for advanced colorectal neoplasia. METHODS: In a retrospective study, we analyzed data from a consecutive series of 3109 participants with positive results from FITs (>= 20 mu g/g of feces) included in the first round of the Barcelona colorectal cancer screening program, from December 2009 through February 2012. All participants underwent colonoscopy and were assigned to groups with any advanced colorectal neoplasia or with nonadvanced colorectal neoplasia (but with another diagnosis or normal examination findings). RESULTS: Median fecal hemoglobin concentrations were significantly higher in participants with advanced colorectal neoplasia (105 mu g/g; interquartile range, 38-288 mu g/g) compared with participants with nonadvanced colorectal neoplasia (47 mu g/g; interquartile range, 23-119 mu g/g) (P < .001). Positive predictive values for advanced colorectal neoplasia, determined using arbitrary fecal hemoglobin concentrations, differed with sex and age. Multivariate logistic regression analysis identified sex (men: odds ratio [OR], 2.07; 95% confidence interval, 1.78-2.41), age (60-69 y: OR, 1.24; 95% confidence interval, 1.07-1.44), and fecal hemoglobin concentration (>177 mu g/g: OR, 3.80; 95% confidence interval, 3.07-4.71) as independent predictive factors for advanced colorectal neoplasia. Combining these factors, we identified 16 risk categories associated with different probabilities of identifying advanced colorectal neoplasia. Risk for advanced colorectal neoplasia increased 11.46-fold among individuals in the highest category compared with the lowest category; positive predictive values ranged from 21.3% to 75.6%. CONCLUSIONS: Fecal hemoglobin concentration, in addition to sex and age, in individuals with positive results from FITs can be used to stratify probability for the detection of advanced colorectal neoplasia. These factors should be used to prioritize individuals for colonoscopy examination.
引用
收藏
页码:628 / +
页数:10
相关论文
共 50 条
  • [21] PRACTICAL EXPERIENCE OF THE FECAL HEMOGLOBIN IMMUNOCHEMICAL TEST IN A COLORECTAL CANCER SCREENING PROGRAM
    Auge, Josep M.
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 5821 - 5821
  • [22] Difference in Performance of Fecal Immunochemical Tests With the Same Hemoglobin Cutoff Concentration in a Nationwide Colorectal Cancer Screening Program
    Chiang, Tsung-Hsien
    Chuang, Shu-Lin
    Chen, Sam Li-Sheng
    Chiu, Han-Mo
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Fann, Jean Ching-Yuan
    Chou, Chu-Kuang
    Lee, Yi-Chia
    Wu, Ming-Shiang
    Chen, Hsiu-Hsi
    [J]. GASTROENTEROLOGY, 2014, 147 (06) : 1317 - 1326
  • [23] Risk of Advanced Colorectal Neoplasia According to Age and Gender
    Kolligs, Frank T.
    Crispin, Alexander
    Munte, Axel
    Wagner, Andreas
    Mansmann, Ulrich
    Goeke, Burkhard
    [J]. PLOS ONE, 2011, 6 (05):
  • [24] Fecal hemoglobin concentrations and personalized screening for colorectal cancer
    Hsu, Chen-Yang
    Chen, Sam Li-Sheng
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Fann, Jean Ching-Yuan
    Lee, Yi-Chia
    Chiu, Han-Mo
    Chen, Hsiu-Hsi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 207 - 208
  • [25] Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy
    Kawamura, Takuji
    Inoue, Takato
    Shinomiya, Ryo
    Sakai, Hiroaki
    Amamiya, Kana
    Sakiyama, Naokuni
    Shirakawa, Atsushi
    Okada, Yusuke
    Sanada, Kasumi
    Nakase, Kojiro
    Mandai, Koichiro
    Suzuki, Azumi
    Kamaguchi, Mai
    Morita, Atsushi
    Nishioji, Kenichi
    Tanaka, Kiyohito
    Uno, Koji
    Yokota, Isao
    Kobayashi, Masao
    Yasuda, Kenjiro
    [J]. JGH OPEN, 2020, 4 (05): : 898 - 902
  • [26] Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
    Wieten, Els
    Schreuders, Eline H.
    Nieuwenburg, Stella A. V.
    Hansen, Bettina E.
    Lansdorp-Vogelaar, Iris
    Kuipers, Ernst J.
    Bruno, Marco J.
    Spaander, Manon C. W.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) : 1771 - 1777
  • [27] Tailoring Colorectal Cancer Screening by Considering Risk of Advanced Proximal Neoplasia
    Imperiale, Thomas F.
    Glowinski, Elizabeth A.
    Lin-Cooper, Ching
    Ransohoff, David F.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2012, 125 (12): : 1181 - 1187
  • [28] Identification of subjects at risk of proximal advanced neoplasia for colorectal cancer screening
    Wong, Martin C. S.
    Ching, Jessica Y. L.
    Chan, Victor C. W.
    Lam, Thomas Y. T.
    Luk, Arthur K. C.
    Wong, Sunny H.
    Ng, Siew C.
    Ng, Simon S. M.
    Wu, Justin C. Y.
    Chan, Francis K. L.
    Sung, Joseph J. Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (01) : 37 - 44
  • [29] Optimizing colorectal cancer screening intervals using fecal hemoglobin concentration: a personalized approach
    Sajjad, Hamza
    Verma, Amogh
    Khatib, Mahalaqua N.
    Zahiruddin, Quazi S.
    Gaidhane, Abhay M.
    Sharma, Rakesh K.
    Rustagi, Sarvesh
    Singh, Mahendra P.
    Tirukelem, Amanuel M.
    [J]. INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 515 - 516
  • [30] A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasia
    Yen, Amy Ming-Fang
    Chen, Sam Li-Sheng
    Chiu, Sherry Yueh-Hsia
    Fann, Jean Ching-Yuan
    Wang, Po-En
    Lin, Sheng-Che
    Chen, Yao-Der
    Liao, Chao-Sheng
    Yeh, Yen-Po
    Lee, Yi-Chia
    Chiu, Han-Mo
    Chen, Hsiu-Hsi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (05) : 1203 - 1212